Roche Diagnostics cobas™ liat SARS-CoV-2 + Influenza A/B Multiplex Assay

The cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B.

Supplier:  Roche Diagnostics 09211101190

Catalog No. 23-312-205

Description

• One sample one test, 20 minutes, know if it's COVID-19 or flu
• Take the workload out of testing with a simple intuitive user handling
• Minimizes cross-contamination and risk of exposure during testing with the closed-system design
• SARS-CoV-2: 100% Positive Agreement, 100% Negative Agreement*

*Compared to an FDA-cleared EUA, cobas SARS-CoV-2 Test on cobas 6800/8800 systems

Specifications

• Certifications/Compliance: CE/EUA
• Control Sets: SARS-CoV-2 & Influenza A/B Control Kit used to verify each new lot of SARS-CoV-2 & Influenza A/B Assay
• CE Marker: Yes
• Detectable Analytes: SARS-CoV-2 ORF 1a/b and N Gene, M gene Inf A, NS gene Inf B
• Type: Assay
• For Use With (Application): RT-PCR
• Packaging Type: 1 Kit
• Test Time: 20 min.

• Content And Storage: 2°C to 8°C
• CPT Code: 87631
• Clia Complexity: Waived (EUA)
• Sample Type: Nasopharyngeal swab, nasal swab
• Disposable: Single-use
• Material: Plastic (assay tube)
• Quantity: 20 Tests/Kit

Safety and Handling

ShelfLife : 150 Days